Women in Endocrinology: ENDO 2017
Women in Endocrinology: ENDO 2017
Women in Endocrinology (WE) Annual Meeting/Dinner
The Women in Endocrinology annual dinner meeting will be held on Friday, April 1st, 2017 from 6:30-10:00 pm in the Hyatt Regency- Regency Ballroom OP in Orlando, FL. The meeting will begin with a chance to mingle and catch up with old friends over cocktails. Our featured speaker will be Dr. Anne Klibanski, who will present a talk entitled, “Navigating an Academic Career." Dr. Kilbanski is the Chief of Neuroendocrine Unit at Massachusetts General Hospital and Laurie Carrol Guthart Professor of Medicine, Harvard Medical School, and Chief Academic Officer, Partners HealthCare, Boston, MA.
This continuing medical education activity should be of substantial interest to Adult and Pediatric Endocrinologists, Internal Medicine and Primary Care Physicians, and Fellows.
- Understand career challenges at different career stages and how to approach them
- Strategizing to move a career forward
- Recognizing and understanding the value of positive and negative mentoring
The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to the Endocrine Society and to learners any relevant financial relationship(s) of the individual or spouse/partner that have occurred within the last 12 months with any commercial interest(s) whose products or services are related to the CME content. Financial relationships are defined by remuneration in any amount from the commercial interest(s) in the form of grants; research support; consulting fees; salary; ownership interest (e.g., stocks, stock options, or ownership interest excluding diversified mutual funds); honoraria or other payments for participation in speakers' bureaus, advisory boards, or boards of directors; or other financial benefits. The intent of this disclosure is not to prevent CME planners with relevant financial relationships from planning or delivery of content, but rather to provide learners with information that allows them to make their own judgments of whether these financial relationships may have influenced the educational activity with regard to exposition or conclusion. The Endocrine Society has reviewed all disclosures and resolved or managed all identified conflicts of interest, as applicable.
The following planners reported the indicated financial relationship(s): Dana Erickson, MD is an advisory group member for Chiasma.
DISCLAIMERS USE OF PROFESSIONAL JUDGMENT:
The educational content in this activity relates to basic principles of diagnosis and therapy and does not substitute for individual patient assessment based on the health care provider’s examination of the patient and consideration of laboratory data and other factors unique to the patient. Standards in medicine change as new data become available.
DRUGS AND DOSAGES:
When prescribing medications, the physician is advised to check the product information sheet accompanying each drug to verify conditions of use and to identify any changes in drug dosage schedule or contraindications.
POLICY ON UNLABELED/OFF-LABEL USE
The Endocrine Society has determined that disclosure of unlabeled/off-label or investigational use of commercial product(s) is informative for audiences and therefore requires this information to be disclosed to the learners at the beginning of the presentation. Uses of specific therapeutic agents, devices, and other products discussed in this educational activity may not be the same as those indicated in product labeling approved by the Food and Drug Administration (FDA). The Endocrine Society requires that any discussions of such “off-label” use be based on scientific research that conforms to generally accepted standards of experimental design, data collection, and data analysis. Before recommending or prescribing any therapeutic agent or device, learners should review the complete prescribing information, including indications, contraindications, warnings, precautions, and adverse events.
PRIVACY AND CONFIDENTIALITY STATEMENT
The Endocrine Society will record learner’s personal information as provided on CME evaluations to allow for issuance and tracking of CME certificates. The Endocrine Society may also track aggregate responses to questions in activities and evaluations and use these data to inform the ongoing evaluation and improvement of its CME program. No individual performance data or any other personal information collected from evaluations will be shared with third parties.
ACKNOWLEDGMENT OF COMMERCIAL SUPPORT
This educational activity is supported by an independent medical educational grant from Pfizer, Ipsen, Novartis.
The Endocrine Society is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The Endocrine Society has achieved Accreditation with Commendation.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Endocrine Society and Women in Endocrinology. The Endocrine Society is accredited by the ACCME to provide continuing medical education for physicians.
The Endocrine Society designates this live activity for a maximum of 0.50 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 0.50 AMA PRA Category 1 Credits™
- 0.50 CME Certificate of Participation